Cytek Biosciences, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
522.84 | 48.77 | 972.03% | 195.88 | 166.92% |
| P/S |
|
6.65 | 33.76 | -80.3% |
|
|
| P/BV |
|
3.27 | 4.82 | -32.25% |
|
|
| P/FCF |
|
2533.04 | 60.98 | 4054.09% |
|
|
| Ev/Ebitda |
|
-67.16 | -22.12 | 203.59% |
|
|
| Ev/S |
|
5.95 | 22.56 | -73.61% |
|
|
| Ev/FCF |
|
2531.67 | 68.75 | 3582.59% |
|
|
| E/P |
|
-0.0106 | 0.0178 | -159.64% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-8.87 | 4.83 | -283.57% | -2.32 | 282.19% |
| ROE |
|
-3.09 | 9.61 | -132.17% |
|
|
| ROA |
|
-2.44 | 0.3359 | -826.69% |
|
|
| ROIC |
|
-0.42 | 7.63 | -105.5% |
|
|
| ROS |
|
-6.29 | -25.17 | -75.01% |
|
|
| ROCE |
|
-6.7 | 15.33 | -143.72% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.4217 | -3.67 | -88.5% | 0.2114 | -299.54% |
| Nеt Debt/Ebitda |
|
7.86 | -3.44 | -328.44% |
|
|
| Debt/Ratio |
|
0.0145 | 0.1972 | -92.64% |
|
|
| Debt/Equity |
|
0.5269 | 1.65 | -68% |
|
|
| Debt/Net Income |
|
-0.5942 | 10.31 | -105.77% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5491 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.0789 | -100% |
|
|
| DSI |
|
0 | 0.2043 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0591 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4924 | -100% |
|
|
| Average percentage for payments |
|
30.86 | 43.56 | -29.16% |
|
|
| Difference from average difference in sector |
|
-0.5491 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
10/10
|
232.78 | -56.89 | -509.18% |
| Growth impulse Ebitda 5 years |
|
7.08 | -64.81 | -110.92% |
| Growth impulse Net Income 5 years |
|
-28.54 | -58.33 | -51.07% |
| Growth impulse FCF 5 years |
|
-103.03 | -47 | 119.21% |
| Growth impulse EPS 5 years |
|
-43.88 | -32.41 | 35.39% |
IP Score
2.62/10
